English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Katherine Tsokas, JD, Janssen Research and Development, LLC; Richard McFarland, PhD, MD, Advanced Regenerative Manufacturing Institute; Carl Burke, PhD, Century Therapeutics; Jessica L. Lynch, PhD, DABT, Janssen Research and Development, LLC; Thomas Bollenbach, PhD, Advanced Regenerative Manufacturing Institute; D. Allen Callaway II, MS, MBA, Janssen Research and Development, LLC; and Jay Siegel, MD, Johnson & Johnson

Reducing Risks and Delays in the Translation of Cell and Gene Therapy Innovations into Regulated Products